ReviewEfficacy of β-hydroxy-β-methylbutyrate supplementation in elderly and clinical populations
Introduction
Muscle loss is common throughout the aging process and may begin as young as 30 y of age [1]. Approximately 30% of muscle mass is lost between the fifth and eighth decades of life and rates of muscle loss can reach up to 15% per decade by 70 y of age [2], [3]. Moreover, low levels of muscle mass in the elderly have been correlated with decreased physical function [4], decreased quality of life [5], and increased mortality [6]. A similar relation exists in many clinical populations such as patients with cancer or acquired immune deficiency syndrome (AIDS), where muscle wasting is common. Indeed, low levels of lean mass in clinical populations have been correlated with decreased physical function, decreased quality of life, poorer response to treatment, and increased mortality [7], [8], [9], [10]. Therefore, interventions to maintain or potentially increase lean mass in elderly and clinical populations are needed. Recently, β-hydroxy-β-methylbutyrate (HMB) has been researched for its muscle-sparing properties in these populations. The present review summarizes the evidence for use of HMB in human elderly and clinical populations.
Section snippets
Methods
Searches were performed using the PubMed database with terms such as HMB, beta-hydroxy-beta-methylbutyrate, HMB muscle, HMB supplementation, and HMB exercise. Results were thoroughly reviewed for primary research studies on HMB supplementation in clinical and elderly populations, HMB supplementation in animal models of disease, HMB safety and dosage studies, and studies on the potential mechanism of action of HMB. In addition, review articles on HMB supplementation were obtained and the
Metabolism and dosage
HMB is a metabolite of the ketogenic amino acid leucine. A small amount (∼0.3–0.4 g/d) of HMB is produced endogenously through leucine metabolism. The first step in leucine oxidation is transamination to ketoisocaproate. The majority (approximately 95%) of ketoisocaproate is metabolized to isovaleryl coenzyme A by the mitochondrial enzyme branched-chain α-keto-acid dehydrogenase and ultimately enters the citric acid cycle. However, a small amount of ketoisocaproate (approximately 5%) is
Safety of HMB
With consumption of any dietary supplement, safety is a concern. Accordingly, the safety of HMB supplementation has been widely studied [17], [18], [19], [20]. Early studies in animals found that the consumption of HMB in dosages as high as 100 g/d in pigs weighing 20 kg (approximately 100 times the HMB dose used in most human studies) for 4 d had no effect on changes in blood cell numbers, organ weights, or histologic lesions [17]. Likewise in humans, the consumption of dosages as high as 6
Efficacy of HMB in healthy populations and athletes
Previous studies investigating HMB supplementation in athletes and healthy populations have shown mixed results. A meta-analysis of nine studies found that HMB resulted in significant gains in muscle size and strength [24]. However, a more recent meta-analysis of 11 studies by Rowlands et al. [25] concluded that 3 to 9 wk of HMB supplementation at a dosage of around 3 g/d resulted in only small to trivial increases in muscle strength and only trivial increases in muscle size, regardless of
Efficacy of HMB in the elderly
The effects of HMB supplementation in elderly populations have been examined in several studies (Table 1) [23], [26], [27], [28], [29]. Hsieh et al. [26] investigated the effects of HMB in elderly subjects receiving tube feeding. The subjects were assigned to usual care (n = 40) or HMB 2 g/d (n = 39) for 28 d. All tube-feeding protocols remained the same throughout the study. After 28 d, HMB supplementation increased weight, body mass index, and waist, hip, and calf circumferences. In addition,
Efficacy of HMB in clinical populations
Patients with a chronic disease such as cancer and AIDS develop significant muscle loss, which leads to decreased physical function, quality of life, and survival [10]. Numerous nutritional interventions have been investigated in an attempt to counteract muscle wasting in these populations; however, many of these interventions have been unsuccessful in attenuating muscle loss (reviewed in Klein et al. [32]). Recently, HMB has been investigated for its anticatabolic effects in clinical
Efficacy of HMB in animal models of disease
The previously discussed studies are the only published investigations on the efficacy of HMB supplementation in human clinical populations. However, HMB supplementation has also been investigated in animal models of muscular unloading, sepsis, and muscular dystrophy. Hao et al. [43] investigated the effects of HMB using an animal model of unloading and reloading. They found that rats supplemented with HMB had significantly greater force production and increased plantaris and soleus
HMB mechanism of action
Muscle tissue mass represents the net balance between muscle protein synthesis and degradation. The continuous process of building and replacing muscle protein allows muscle to repair and adapt to environmental conditions. Net protein balance is positive during growth when protein synthesis exceeds degradation, whereas the net balance is negative during weight loss, aging, and in clinical populations when degradation exceeds synthesis. Accordingly, numerous studies have investigated the effects
Conclusions
Muscle loss is common during aging and in chronic diseases, leading to decreased physical function, a decreased quality of life, and increased mortality. Recently, HMB has been shown to attenuate muscle loss in the elderly and in clinical populations such as patients with AIDS and those with cancer; however, a limited number of studies have investigated this question, with relatively small samples. In addition, the effects of HMB in clinical populations appear to differ depending on the
References (58)
- et al.
Lower extremity muscle mass predicts functional performance in mobility-limited elders
J Nutr Health Aging
(2008) - et al.
Sarcopenia and mortality among older nursing home residents
J Am Med Dir Assoc
(2012) - et al.
The role of objective measurement of skeletal muscle function in the pre-operative patient
Clin Nutr
(1989) - et al.
Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?
Eur J Cancer
(1998) - et al.
beta-hydroxy-beta-methylbutyrate (HMB) kinetics and the influence of glucose ingestion in humans
J Nutr Biochem
(2001) - et al.
Nutritional role of the leucine metabolite B-hydroxy B-methylbutyrate (HMB)
J Nutr Biochem
(1997) - et al.
Beta-hydroxy-beta-methylbutyrate (HMB) supplementation in humans is safe and may decrease cardiovascular risk factors
J Nutr
(2000) - et al.
Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine
Am J Surg
(2002) - et al.
Body composition in 70-year-old adults responds to dietary beta-hydroxy-beta-methylbutyrate similarly to that of young adults
J Nutr
(2001) - et al.
Effect of beta-hydroxy-beta-methylbutyrate, arginine, and lysine supplementation on strength, functionality, body composition, and protein metabolism in elderly women
Nutrition
(2004)
A simple recording grip strength device
Pharmacol Biochem Behav
Nutrition support in clinical practice: review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition
Am J Clin Nutr
Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial
Clin Nutr
Beta-hydroxy-beta-methylbutyrate supplementation reduces tumor growth and tumor cell proliferation ex vivo and prevents cachexia in Walker 256 tumor-bearing rats by modifying nuclear factor-kappaB expression
Nutr Res
Beta-hydroxy-beta-methylbutyrate supplementation affects Walker 256 tumor-bearing rats in a time-dependent manner
Clin Nutr
Effect of beta-hydroxy-beta-methylbutyrate (HMB) on protein metabolism in whole body and in selected tissues
Food Chem Toxicol
Beta-hydroxy-beta-methylbutyrate (HMB) stimulates myogenic cell proliferation, differentiation and survival via the MAPK/ERK and PI3K/Akt pathways
Biochim Biophys Acta
Beta-hydroxy-beta-methylbutyrate modifies human peripheral blood mononuclear cell proliferation and cytokine production in vitro
Nutrition
Skeletal muscle mass and distribution in 468 men and women aged 18–88 yr
J Appl Physiol
The ageing muscle
Clin Physiol
Muscle strength and speed of movement in relation to age and muscle morphology
J Appl Physiol
Skeletal muscle fiber quality in older men and women
Am J Physiol Cell Physiol
Are there clinical and laboratory predictors of 5-year mortality in HIV-infected children and adolescents with hemophilia?
J Acquir Immune Defic Syndr
Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies
Annu Rev Med
Oxidation of leucine and alpha-ketoisocapruate to beta-hydroxy beta-methylbutyrate in vivo
Am J Physiol Endocrinol Metab
Effects of beta-hydroxy-beta-methylbutyrate (HMB) on exercise performance and body composition across varying levels of age, sex, and training experience: a review
Nutr Metab
National nutrient database for standard reference [database on Internet]
Beta-hydroxy-beta-methylbutyrate ingestion, part I: effects on strength and fat free mass
Med Sci Sports Exerc
Effect of leucine metabolite beta-hydroxy-beta-methylbutyrate on muscle metabolism during resistance-exercise training
J Appl Physiol
Cited by (90)
Revisiting Cancer Cachexia: Pathogenesis, Diagnosis, and Current Treatment Approaches
2021, Asia-Pacific Journal of Oncology NursingCitation Excerpt :An increase of 300–400 kcal and 50% of extraprotein is required daily for an effective anabolic resistance. A favorable effect in cachetic states was seen with some nutritional supplements such as β-hydroxy-β-methylbutyrate (HMB),53,54 eico-sapentaenoic acid,55,56 and with L-carnitine.57,58 However, recent review pointed out at limited evidence in favor of using HMB and L-carnitine.59
Effects of β-hydroxy-β-methylbutyrate (HMB) supplementation on biomarkers for cognitive function and electrophysiological processes in aging
2021, Factors Affecting Neurological Aging: Genetics, Neurology, Behavior, and DietSurface analysis of etched enamel modified during the prenatal period
2019, Spectrochimica Acta - Part A: Molecular and Biomolecular SpectroscopyCitation Excerpt :A series of studies have shown that it is possible to influence the mechanical, morphological and physiological features of tissues of offspring during the prenatal period by supplementation of pregnant dams with β-hydroxy β-methylbutyrate (HMB) [8–13]. This metabolite of leucine is produced endogenously in a two-step process starting with leucine transamination to α-ketoisocaproate which, in turn, is metabolized by the α-keto-acid dehydrogenase and ultimately enters the citric acid cycle [14]. HMB could affect protein metabolism in multiple ways, e.g. inhibiting proteolysis, attenuating depression in protein synthesis, metabolic inhibitors and promoting protein synthesis [15–18].
Prevalence of sarcopenia and associated factors in institutionalised older adult patients
2018, Clinical Nutrition ESPENCitation Excerpt :In case of acute or chronic disease the recommended intake should be 1.2–1.5 g/kg BW/day [25,26]. On the other hand, dietary enrichment with leucine or a mixture of branched-chain amino acids may help enhance muscle mass and muscle function, but further studies are needed to support specific recommendations [20,25,30,31]. Finally, epidemiological studies indicate that Vitamin D low levels are associated with low muscle mass and strength [32].